share_log

北京コンチネント社 F351に関する研究論文についてのリリース

Release of research paper on Beijing Component Co., Ltd.'s F351.

GNI Group ·  Jun 17 11:00

Announcements of individual stocks regarding research papers on F351, which we introduced on May 30th, have been released by our subsidiary Beijing Continent.
According to this release, it is stated that there is a possibility of improvement in liver fibrosis and that the number of liver fibrosis patients in China is as high as 150 million.
For more information, please refer to the following.

https://mp.weixin.qq.com/s/baPNON7WL-ba0S0MWhFirQ

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment